We perform a large scale ABCA4 genotyping in patients from Central Europe.
We screen ABCA4 with the most advanced DNA sequencing technology.
The relevance of genetic variants is defined based on population evidence.
We identify several novel ABCA4 gene mutations and a novel complex allele.
The pathogenic status of several ABCA4 variants is disproved.